Intermittent Catheters - Global Strategic Business Report

Global Intermittent Catheters Market to Reach $3.2 Billion by 2030

The global market for Intermittent Catheters estimated at US$2.3 Billion in the year 2022, is projected to reach a revised size of US$3.2 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2022-2030. Urinary Incontinence, one of the segments analyzed in the report, is projected to record 3.9% CAGR and reach US$1.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Spinal Cord Injuries segment is readjusted to a revised 5.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $692.6 Million, While China is Forecast to Grow at 3.9% CAGR

The Intermittent Catheters market in the U.S. is estimated at US$692.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$565.3 Million by the year 2030 trailing a CAGR of 3.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 3.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Select Competitors (Total 41 Featured) -

• Adapta Medical, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Coloplast A/S
• Cure Medical LLC
• Hollister, Inc.
• Medical Technologies of Georgia, Inc.
• Pennine Healthcare Ltd.
• Teleflex, Inc.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year